Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT5B | P51692 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20048208 | 0.72 | STAT5B (0.39) | STAT5B | |
| SCHEMBL23615869 | 0.71 | STAT5B (0.46) | STAT5BTSHRNPSR1 | |
| SCHEMBL20041810 | 0.68 | STAT5B (0.42) | STAT5B | |
| SCHEMBL13343501 | 0.62 | KMT2A (0.50) | TSHRNPSR1 | |
| SCHEMBL22096015 | 0.61 | STAT5B (1.00) | STAT5BTSHR | |
| SCHEMBL10000161 | 0.61 | NPSR1 (0.46) | STAT5BTSHRNPSR1 | |
| SCHEMBL23615919 | 0.60 | STAT5B (0.40) | STAT5BTSHR | |
| SCHEMBL22213898 | 0.60 | NPSR1 (0.45) | STAT5BTSHRNPSR1 | |
| SCHEMBL17950597 | 0.59 | NPSR1 (0.48) | STAT5BTSHRNPSR1 | |
| SCHEMBL8936043 | 0.57 | NPSR1 (0.42) | STAT5BTSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3523297-B1 | NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER | UNIV BERLIN FREIE (DE) | 2021-07-07 | — | — | EP | disclosed |
| WO-2018065536-A1 | NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER | FREIE UNIVERSITÄT BERLIN (DE) | 2018-04-12 | — | — | WO | disclosed |
| EP-3305783-A1 | NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER | Freie Universität Berlin (DE) | 2018-04-11 | — | — | EP | disclosed |